{"id":"W4416139653","doi":"10.1093/neuonc/noaf201.1686","title":"TIP-26. A phase II study evaluating the safety, efficacy, and intracranial activity of tarlatamab in recurrent/refractory <i>IDH</i> -mutant gliomas (TARGID)","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Clinical endpoint; Cohort; Refractory (planetary science); Phases of clinical research; Population; Glioma; Progressive disease; Cytotoxic T cell; Astrocytoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006999689,0.0009486298,0.00117486,0.000313242,0.0002265132,0.000789328,0.0006142459,0.0007972935,0.003190719],"category_scores_gemma":[0.0004148202,0.000359702,0.0006806433,0.0002427026,0.0006216356,0.0005791371,0.0002235434,0.002302832,0.0008839419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005485344,"about_ca_system_score_gemma":0.001079046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006521204,"about_ca_topic_score_gemma":0.001614011,"domain_scores_codex":[0.9998341,0.00005863673,0.000009057238,0.00003323161,0.00001997729,0.00004494569],"domain_scores_gemma":[0.9996227,0.00004563017,0.00006266499,0.00002939998,0.00002056826,0.0002189814],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5822772,0.07670581,0.009144357,0.001227771,0.0009974524,0.0008431028,0.0002497713,0.004121498,0.179763,0.000684465,0.0106506,0.1333349],"study_design_scores_gemma":[0.3171867,0.6458336,0.01072926,0.00004319873,0.0004161729,0.0007733717,0.00008626346,0.002337055,0.01781445,0.0003059857,0.004433114,0.00004092073],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992964,0.001300006,0.0004276863,0.0002520895,0.00008669635,0.001484822,0.001613094,0.0001081936,0.001763417],"genre_scores_gemma":[0.9898117,0.001228337,0.001285529,0.000511079,0.00009824619,0.001572822,0.003230856,0.00003591827,0.002225498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003190719,"threshold_uncertainty_score":0.01067406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03478204104979758,"score_gpt":0.3822289957258793,"score_spread":0.3474469546760817,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}